Nidan Laboratories and Healthcare Limited (NSE: NIDAN), ISIN INE0J6L01013 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
NIDAN last traded at ₹12.50 (-3.10%), with a 52-week range of ₹11.50 to ₹24.90 (as of 24 Jul 2026).
Shareholding as of Mar 2026: promoters 57.04%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 15/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.